ECSP11011497A - Radiotrazadores pet para la imagimática del metabolismo y conservación de ácidos grasos - Google Patents

Radiotrazadores pet para la imagimática del metabolismo y conservación de ácidos grasos

Info

Publication number
ECSP11011497A
ECSP11011497A ECSP11011497A ECSP11011497A EC SP11011497 A ECSP11011497 A EC SP11011497A EC SP11011497 A ECSP11011497 A EC SP11011497A EC SP11011497 A ECSP11011497 A EC SP11011497A
Authority
EC
Ecuador
Prior art keywords
fatty acids
metabolism
radiotrazers
imagimatics
conservation
Prior art date
Application number
Other languages
English (en)
Inventor
Robert H Mach
Robert John Gropler
Zhude Tu
Pilar Herrero
Original Assignee
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Washington filed Critical Univ Washington
Publication of ECSP11011497A publication Critical patent/ECSP11011497A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/132Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0402Organic compounds carboxylic acid carriers, fatty acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/09Preparation of carboxylic acids or their salts, halides or anhydrides from carboxylic acid esters or lactones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/15Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/58Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/041,2,3-Triazoles; Hydrogenated 1,2,3-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Se describen moléculas del análogo de ácido graso (FAA) que comprenden radionúclidos, de emisión de positrones, sales de éstos, y FAA-triglicéridos. Se describen, además, los métodos de síntesis, y métodos de distribución de imágenes y metabolismo de los ácidos grasos y triglicéridos de ácidos grasos.
ECSP11011497 2009-05-04 2011-12-01 Radiotrazadores pet para la imagimática del metabolismo y conservación de ácidos grasos ECSP11011497A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17506509P 2009-05-04 2009-05-04

Publications (1)

Publication Number Publication Date
ECSP11011497A true ECSP11011497A (es) 2012-03-30

Family

ID=43050827

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP11011497 ECSP11011497A (es) 2009-05-04 2011-12-01 Radiotrazadores pet para la imagimática del metabolismo y conservación de ácidos grasos

Country Status (19)

Country Link
US (1) US20120100073A1 (es)
EP (1) EP2427218A4 (es)
JP (1) JP2012526129A (es)
KR (1) KR20120060943A (es)
CN (1) CN102421454A (es)
AU (1) AU2010246010A1 (es)
BR (1) BRPI1014538A2 (es)
CA (1) CA2760334A1 (es)
CL (1) CL2011002753A1 (es)
CO (1) CO6460756A2 (es)
CR (1) CR20110637A (es)
EA (1) EA201171355A1 (es)
EC (1) ECSP11011497A (es)
IL (1) IL216124A0 (es)
MX (1) MX2011011743A (es)
NO (1) NO20111663A1 (es)
SG (1) SG175430A1 (es)
WO (1) WO2010129572A2 (es)
ZA (1) ZA201108053B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201021369D0 (en) * 2010-12-16 2011-01-26 Ge Healthcare Ltd Radioiodinated fatty acids
WO2014030650A1 (ja) 2012-08-20 2014-02-27 大塚製薬株式会社 糖代謝能の測定方法及びそれに使用する組成物
KR20150132301A (ko) * 2013-03-15 2015-11-25 오츠카 세이야쿠 가부시키가이샤 지방산 연소에 의한 인슐린 저항성의 측정 방법, 및 그에 사용하는 조성물
US20160185735A1 (en) * 2013-08-12 2016-06-30 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Fatty acid analogs and their use
US10457642B2 (en) 2015-05-04 2019-10-29 The Trustees Of The University Of Pennsylvania 211-astatine containing radiotherapeutics for the treatment of cancer
EP3825302A4 (en) 2018-07-20 2022-05-04 Astellas Pharma Inc. FATTY ACID DERIVATIVE LABELED WITH POSITRON-emitting radionuclide
WO2021145403A1 (ja) * 2020-01-17 2021-07-22 アステラス製薬株式会社 陽電子放出核種で標識された脂肪酸誘導体

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2846491A (en) * 1955-12-13 1958-08-05 Air Reduction Reactions of sodium acetylide with alkyl halides
EP0136879A3 (en) * 1983-09-30 1987-01-07 Yamanouchi Pharmaceutical Co., Ltd. Fatty acid derivatives and processes of producing them
EP0327523B1 (en) * 1988-02-03 1992-06-17 Washington University Novel fatty acid analog enzyme substrates
ES2088480T3 (es) * 1990-10-12 1996-08-16 Univ Washington Sustratos de enzimas analogos de acidos grasos sustituidos con azido.
US5401493A (en) * 1993-03-26 1995-03-28 Molecular Biosystems, Inc. Perfluoro-1H,-1H-neopentyl containing contrast agents and method to use same
US5747537A (en) * 1995-09-05 1998-05-05 Washington University Method of inhibiting parasitic activity
ATE353019T1 (de) * 1995-12-01 2007-02-15 Molecular Insight Pharm Inc Stereoisomere von fettsäureanalogen zur diagnostischen bildgebung
JP4415216B2 (ja) * 2002-02-01 2010-02-17 大日本住友製薬株式会社 2−フランカルボン酸ヒドラジド化合物及びそれを含有する医薬組成物
WO2004093650A2 (en) * 2003-04-17 2004-11-04 The General Hospital Corporation Method for monitoring blood flow and metabolic uptake in tissue with radiolabeled alkanoic acid
CN1886362B (zh) * 2003-07-24 2010-10-13 皇后医学中心 烷基化剂的制备和用途
JP4455413B2 (ja) * 2004-06-11 2010-04-21 キヤノン株式会社 ビニル基、エステル基、カルボキシル基並びにスルホン酸基を有するポリヒドロキシアルカン酸並びにその製造方法

Also Published As

Publication number Publication date
CL2011002753A1 (es) 2012-07-13
EA201171355A1 (ru) 2012-05-30
US20120100073A1 (en) 2012-04-26
WO2010129572A3 (en) 2010-12-29
CR20110637A (es) 2012-02-09
CA2760334A1 (en) 2010-11-11
KR20120060943A (ko) 2012-06-12
CO6460756A2 (es) 2012-06-15
ZA201108053B (en) 2012-07-25
WO2010129572A2 (en) 2010-11-11
AU2010246010A1 (en) 2011-11-17
IL216124A0 (en) 2012-01-31
MX2011011743A (es) 2011-11-29
NO20111663A1 (no) 2011-12-02
EP2427218A2 (en) 2012-03-14
BRPI1014538A2 (pt) 2016-04-05
JP2012526129A (ja) 2012-10-25
CN102421454A (zh) 2012-04-18
EP2427218A4 (en) 2014-06-18
SG175430A1 (en) 2011-12-29

Similar Documents

Publication Publication Date Title
ECSP11011497A (es) Radiotrazadores pet para la imagimática del metabolismo y conservación de ácidos grasos
CL2020002805A1 (es) Método para identificar un modulador de un sistema biológico; método para identificar un modulador de un proceso de enfermedad (divisional 201302526)
ES2535839T3 (es) Composición de un gel que comprende pectina ligeramente metoxilada
CU20190058A7 (es) Composiciones de aminoácidos relacionadas con mejoras de la función hepática
AR085507A1 (es) Animales modificados geneticamente y metodos para su obtencion
UY31858A (es) 3-metil-7-(2-butin-1-il)-8-(3-(r)-amino-piperidin-1-il)-xantinas y sus sales farmacéuticamente aceptables como inhibidores de dpp-4 para aplicaciones terapéuticas
ECSP13012715A (es) Método para producir preparados farmacéuticos con contenido de ibp
EA201590026A1 (ru) Выработка длинноцепочечных полиненасыщенных жирных кислот в растительных клетках
ES2643848T3 (es) Método para cuantificar dosis UV desinfectantes usando indicadores
UY32037A (es) Daa-piridina
NI201100205A (es) Sales de disacarina, ácido difumárico, acido di - 1 - hidroxi - 2 - naftoico y ácido monobenzoico del 2 - ( 4 - (( 2 - amino - 4 - metil - 6 - ( pentilamino ) pirimidin - 5 - il ) metil ) fenil ) acetato de 4 - ( dimetilamino ) butilo
BR112012018131A2 (pt) aparelho, servidor, método e sistema de agrupamento de produto, e, meio de gravação
CL2013001604A1 (es) Compuestos derivados de pirimidinona sustituida; composicion farmaceutica que los comprende; su uso para tratar la enfermedad de alzheimer y la aterosclerosis.
BR112015030268A2 (pt) composição farmacêutica, recipiente, kit, e, método para a preparação de uma composição
CU20120162A7 (es) Colorantes de perileno enlazados a polímero y composiciones que los contienen
ES2596248T3 (es) N-Carbamoilputrescina para mejorar la síntesis de proteínas musculares
ES2508165T3 (es) Lactoferrina y sustancia blanca
BR112015030135A2 (pt) ésteres de ácidos oligo-hidróxi carboxílicos e seu uso
BR112012016054A2 (pt) Composições nutricionais compreendendo flocos de fruta incluindo ácido docosa-hexaenoico
UY35856A (es) Producción de acidos grasos poliinsaturados de cadena larga omega 3 en los cultivos de oleaginosas por una sintasa pufa traustoquitridio.
AR081465A1 (es) Uso de marcadores especificos de gen nervadura-3 marron (“brown 3-midrib”) en maiz para introgresion de rasgos
CL2016002362A1 (es) Composiciones semioquímicas para reducir conflictos sociales con gatos.
AR092423A1 (es) Metodo de diagnostico y tratamiento del cancer dirigido a las moleculas expresadas en celulas madre cancerosas
BR112014008527A2 (pt) núcleo absorvente
CL2011000621A1 (es) Agente que contiene por lo menos un acido acilciclohexanodionacarboxilico y/o sus sales en combinacion con por lo menos un ester de acido acilciclohexanodionacarboxilico y su uso para mejorar el desarrollo de gramineas.